SCHEMBL7985332

SCHEMBL7985332

O=c1[nH]c(-c2cccc(O)c2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.55
ALDH1A1 P00352 3/20 0.55
HPGD P15428 2/20 0.53
KMT2A Q03164 2/20 0.52
PARN O95453 1/20 0.43
CNOT7 Q9UIV1 1/20 0.43
GAA P10253 1/20 0.42
PTPN1 P18031 1/20 0.41
PNP P00491 2/20 0.41
ADORA3 P0DMS8 2/20 0.40
BRD4 O60885 1/20 0.40
CXCR2 P25025 1/20 0.40
XBP1 P17861 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RNASEL Q05823 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991645 0.92 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL7988785 0.91 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2APARN
SCHEMBL7985609 0.91 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7985561 0.91 HPGD (0.46) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7974245 0.90 HPGD (0.45) SMN1; SMN2ALDH1A1HPGDKMT2AGAA
SCHEMBL7991634 0.90 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL7984403 0.89 CNOT7 (0.47) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7975265 0.89 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDKMT2APARN
SCHEMBL7974275 0.88 HPGD (0.43) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4
SCHEMBL7984655 0.88 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDKMT2APARN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed